Patents by Inventor Zhi Hong

Zhi Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080119420
    Abstract: Two hitherto unreported novel triterpene saponins were isolated in substantially pure form from the root of Ilex pubescens. The chemical structures and some properties of the triterpene saponin fraction have been elucidated to possess anti-inflammatory and analgesic activity. These two novel triterpene saponins and the triterpene saponin fraction may be used as pharmaceutical compositions in humans and mammals in need of such treatment.
    Type: Application
    Filed: November 17, 2006
    Publication date: May 22, 2008
    Inventors: Liang LIU, Jing Rong Wang, Hua Zhou, Zhi Hong Jiang
  • Patent number: 7371857
    Abstract: A hydroxyalkylated heterocyclic base is prepared by reacting a heterocyclic base with an alkylene carbonate in dimethylacetamide as a solvent, wherein the hydroxyalkylated heterocyclic base is isolated from the solvent using isopropanol or tert-butylmethylether.
    Type: Grant
    Filed: August 8, 2002
    Date of Patent: May 13, 2008
    Assignee: Valeant Research & Development
    Inventors: Kanda Ramasamy, Jean-Luc Girardet, Haoyun An, Zhi Hong, Robert Orr
  • Publication number: 20080058340
    Abstract: This invention concerns N-(2-arylamino) aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.
    Type: Application
    Filed: July 30, 2007
    Publication date: March 6, 2008
    Applicant: ARDEA BIOSCIENCES, INC.
    Inventors: Andreas Maderna, Jean-Michel Vernier, Dinesh Barawkar, Varaprasad Chamakura, Hassan El Abdellaoui, Zhi Hong
  • Publication number: 20080047161
    Abstract: A semiconductor drying process apparatus comprising a processing chamber; two or more inlet/outlet openings formed in the processing chamber; a first pipe member coupled in fluid communication between one or more of the inlet/outlet openings of the processing chamber and a first drain valve; a second pipe member coupled in fluid communication between one or more other ones of the inlet/outlet openings of the processing chamber and a first supply valve; and wherein the first pipe member is coupled in fluid communication to the second pipe member for increasing the flow capacity of the semiconductor drying process apparatus.
    Type: Application
    Filed: August 24, 2006
    Publication date: February 28, 2008
    Inventors: Yu Fei Goh, Zhen Qing Lu, Zhi Hong Yi, Beng Lark Lee
  • Publication number: 20070244164
    Abstract: This invention concerns N-(ortho phenylamino dihydropyridyl)sulfonamides and N-(ortho phenylamino dihydropyridyl), N?-alkyl sulfamides which are inhibitors of MEK and are useful in the treatment of cancer and other hyperproliferative diseases.
    Type: Application
    Filed: April 18, 2007
    Publication date: October 18, 2007
    Applicant: ARDEA BIOSCIENCES
    Inventors: Shunqi Yan, Jean-Michel Vernier, Zhi Hong, Suetying Chow, Yung-hyo Koh
  • Publication number: 20070238710
    Abstract: This invention concerns N-(ortho phenylaminoaryl), N?-alkyl sulfamides which are inhibitors of MEK and are useful in the treatment of cancer and other hyperproliferative diseases.
    Type: Application
    Filed: April 11, 2007
    Publication date: October 11, 2007
    Applicant: ARDEA BIOSCIENCES
    Inventors: Shunqi Yan, Jean-Michel Vernier, Zhi Hong
  • Patent number: 7247621
    Abstract: Pharmaceutical compositions comprise a nucleotide analog with a phosphonate group at a concentration effective to act as a substrate and/or inhibitor of a viral polymerase, and especially of the HCV RNA dependent RNA polymerase.
    Type: Grant
    Filed: April 29, 2003
    Date of Patent: July 24, 2007
    Assignee: Valeant Research & Development
    Inventors: Zhi Hong, Yung-hyo Koh, Jae Hoon Shim, Jean-Luc Girardet
  • Publication number: 20070154066
    Abstract: An object tracking method may include: receiving frames of data containing image information of an object; performing an object segmentation to obtain an object motion result; and using the object motion result to conduct an object tracking. In particular, the object segmentation may include: extracting motion vectors from the frames of data; estimating a global motion using the motion vectors; and subtracting the global motion from the motion vectors to generate an object motion result.
    Type: Application
    Filed: May 22, 2006
    Publication date: July 5, 2007
    Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Chia-Wen LIN, Zhi-Hong LING, Kual-Zheng LEE
  • Publication number: 20070125173
    Abstract: An ergonomic inertial positioning system comprises a motion sensor, an angle sensor, and a processor. The motion sensor detects movement of an object. The angle sensor detects angle variation of the heading of the object. The processor determines motion status of the object based on detected data provided by the motion sensor and the angle sensor, and calculates displacement of the object utilizing the detected angle variation thereof based on the motion status.
    Type: Application
    Filed: March 2, 2006
    Publication date: June 7, 2007
    Inventors: Chih-Hung Lin, Zhi-Hong Zhu, Yung-Jin Wu, Tung-Wu Lu, Shih-Hsiang Liu
  • Patent number: 7217815
    Abstract: Various 2?-beta-methyl-6-substituted adenosine analogs (including 2,6-disubstituted adenosine, 8-aza-6-substituted adenosine, and 2-aza-6-substituted adenosine) are prepared by conventional and combinatorial library approaches. Contemplated compounds are particularly useful as therapeutic agents, and especially as antiviral agents.
    Type: Grant
    Filed: October 23, 2002
    Date of Patent: May 15, 2007
    Assignee: Valeant Pharmaceuticals North America
    Inventors: Haoyun An, Yili Ding, Stephanie Z. Shaw, Zhi Hong
  • Publication number: 20070032448
    Abstract: Various 2?-modified nucleoside analogs and corresponding prodrugs are provided, and particularly contemplated methods of use include use as antiviral agents, and especially as antiviral agents against HCV.
    Type: Application
    Filed: October 2, 2002
    Publication date: February 8, 2007
    Inventors: Zhi Hong, Hadylin An, Yili Ding, Jean-Luc Girardet, Weidong Zhong
  • Publication number: 20060282600
    Abstract: A circuit for identifying a CPU Front Side Bus (FSB) is provided. In one preferred embodiment, the circuit includes a CPU, a north bridge, and a control circuit. The CPU has a plurality of Bus Speed Select (BSEL) ends for transmitting FSB BSEL signals. The north bridge also has a plurality of BSEL ends for receiving the FSB BSEL signals sent from the CPU. The control unit connects the CPU and the north bridge. When the CPU FSB exceeds an identifying range of the north bridge, the control circuit converts the FSB BSEL signals to signals which the north bridge can identify. The circuit can identify a higher FSB of the CPU by using the north bridge that usually only supports lower FSB frequencies.
    Type: Application
    Filed: May 16, 2006
    Publication date: December 14, 2006
    Applicant: HON HAI Precision Industry CO., LTD.
    Inventor: Zhi-Hong Wang
  • Publication number: 20060270725
    Abstract: A series of S-triazolyl ?-mercaptoacetanilides having N-(?-mercaptoacetyl) p amino benzoic acid derivatives. are provided, where Q is CO2H, or a salt or ester thereof, or a C(O)N-linked amino acid. The compounds inhibit several variants of the reverse transcriptase of HIV, and are useful in the treatment of HIV infections.
    Type: Application
    Filed: November 30, 2005
    Publication date: November 30, 2006
    Inventors: Jean-Luc Girardet, Yung-hyo Koh, Martha de la Rosa, Zhi Hong, Stanley Lang
  • Publication number: 20060205026
    Abstract: A parallel inducible cell-based kinase screen (PICKS) includes a plurality of cells that express a kinase gene under the control of an inducer and a reporter gene, wherein the cells are derived from a single cell line, and wherein the reporter gene generate a signal in response to catalytic activity or inhibition of the expressed kinases. Particularly preferred systems include cells expressing kinases from a single kinase signaling pathway, kinases from a kinase family, and/or kinases from various different kinase signaling pathways. Consequently, contemplated systems provide a platform for screening for novel kinase inhibitors, inhibition specificity of particular kinase inhibitors, and for analysis of inter-pathway and/or intra-pathway inhibition of a kinase inhibitor.
    Type: Application
    Filed: December 19, 2002
    Publication date: September 14, 2006
    Applicant: Valeant Research & Development
    Inventors: Zhi Hong, William Ricketts, Paul Diaz
  • Publication number: 20060194802
    Abstract: The invention concerns compounds which inhibit MEK and which have activity as anti-neoplastic agents. These compounds include N-substituted-3-hydroxy-5-arylamino-isothiazole-4-carboxamidines. Also included are the tautomeric isothiazol-3(2H)-ones.
    Type: Application
    Filed: January 20, 2006
    Publication date: August 31, 2006
    Inventors: Hassan Abdellaoui, Robert Tam, Huanming Chen, Varaprasad Chamakura, Dinesh Barawkar, Andreas Maderna, Zhi Hong, Stanley Lang
  • Publication number: 20060183706
    Abstract: Various 2?-beta-methyl-6-substituted adenosine analogs (including 2,6-disubstituted adenosine, 8-aza-6-substituted adenosine, and 2-aza-6-substituted adenosine) are prepared by conventional and combinatorial library approaches. Contemplated compounds are particularly useful as therapeutic agents, and especially as antiviral agents.
    Type: Application
    Filed: October 23, 2002
    Publication date: August 17, 2006
    Inventors: An Haoyun, Yili Ding, Stephanie Shaw, Zhi Hong
  • Patent number: 7081449
    Abstract: A purine nucleoside analog includes a pyrido[2,3-d]pyrimidine or a pyrimido[4,5-d]pyrimidine and further has a sugar moiety that is optionally modified at the C2?, C3?, C4? and/or C5? position. Particularly contemplated compounds also include prodrug forms of the purine nucleoside analogs, and both purine nucleoside analogs and the corresponding prodrugs are employed in the reduction of growth of neoplastic cells.
    Type: Grant
    Filed: July 3, 2001
    Date of Patent: July 25, 2006
    Assignee: Valeant Research & Development
    Inventors: Zbigniew Pietrzkowski, Guangyi Wang, Johnson Lau, Zhi Hong, Jean-Luc Girardet, Esmir Gunic
  • Publication number: 20060135556
    Abstract: Various carbonyl amides are employed in vitro and in vivo as non-nucleoside inhibitors of a reverse transcriptase, and particularly of HIV reverse transcriptase. Therefore, contemplated compounds may be employed in the treatment of HIV infected patients. Further contemplated aspects include pharmaceutical compositions comprising therapeutically effective amounts of contemplated compounds.
    Type: Application
    Filed: August 22, 2003
    Publication date: June 22, 2006
    Inventors: Jean-Luc Girardet, Zhijun Zhang, Robert Hamatake, Martha de la Rosa, Esmir Gunic, Zhi Hong, Hong Kim, Yung-Hyo Koh, Shahul Nilar, Stephanie Shaw, Nanhua Yao
  • Publication number: 20060135768
    Abstract: A hydroxyalkylated heterocyclic base is prepared by reacting a heterocyclic base with an alkylene carbonate in dimethylacetamide as a solvent, wherein the hydroxyalkylated heterocyclic base is isolated from the solvent using isopropanol or tert-butylmethylether.
    Type: Application
    Filed: August 8, 2002
    Publication date: June 22, 2006
    Applicant: RIBAPHARM INC.
    Inventors: Kanda Ramasamy, Jean-Luc Girardet, Haoyun An, Zhi Hong, Robert Orr
  • Patent number: 7040031
    Abstract: A level (100) includes a light source (10) and a cone-shaped reflecting element (40) with reflecting surface for reflecting light beam from the light source to produce a circumferential leveling plane. The light source is arranged adjacent to the peak of the cone-shaped reflecting element, and on the center axis of the cone-shaped reflecting element.
    Type: Grant
    Filed: June 21, 2004
    Date of Patent: May 9, 2006
    Assignee: Asia Optical Co., Inc.
    Inventors: Chien-Jen Chen, Zhi-hong Fang